Activation of Procollagenases Is a Key Control Point in Cartilage Collagen Degradation: Interaction of Serine and Metalloproteinase Pathways

Arthritis and Rheumatism

Volumn 44, Issue 9, 2001, Pages 2084-2096

  Milner, J M ^a,b   Elliott, S F ^a   Cawston, T E ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; COLLAGEN; COLLAGENASE; DRUG DERIVATIVE; ENZYME PRECURSOR; FIBRINOLYTIC AGENT; GROWTH INHIBITOR; INTERLEUKIN 1; ONCOSTATIN M; OSM PROTEIN, HUMAN; PEPTIDE; PHENYLALANINE; PLASMINOGEN; PROCOLLAGENASE; PROTEINASE INHIBITOR; SERINE PROTEINASE; STROMELYSIN; THIOPHENE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL; ARTICLE; ARTICULAR CARTILAGE; CATTLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; COLLAGEN; COLLAGENASES; ENZYME ACTIVATION; ENZYME PRECURSORS; FIBRINOLYTIC AGENTS; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 3; ONCOSTATIN M; PEPTIDES; PHENYLALANINE; PLASMINOGEN; PROTEASE INHIBITORS; SERINE ENDOPEPTIDASES; THIOPHENES; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0035464376     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200109)44:9<2084::AID-ART359>3.0.CO;2-R     Document Type: Article

References (86)

1. Muir H. The chondrocyte, architect of cartilage - biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 1995;17:1039-48.
2. Dingle JT, Page TDP, King B, Bard DR. In vivo studies of articular tissue damage mediated by catabolin/interleukin 1. Ann Rheum Dis 1987;46:527-33.
3. Saklatvala J, Pilsworth LM, Sarsfield SJ, Gavrilovic J, Heath JK. Pig catabolin is a form of interleukin 1: cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J 1984;224:461-6.
4. Steinberg JJ, Hubbard JR, Sledge CB. Chondrocyte-mediated breakdown of cartilage. J Rheumatol 1987;14:55-8.
5. Page TDP, King B, Stephens T, Dingle JT. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1. Ann Rheum Dis 1991;50:75-80.
6. Jubb RW, Fell HB. The breakdown of collagen by chondrocytes. J Pathol 1980;130:159-67.
7. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
8. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-63.
9. Cawston TE, Plumpton TA, Curry V, Ellis AJ, Powell L. Role of TIMP and MMP inhibition in preventing connective tissue breakdown. Ann N Y Acad Sci 1994;732:75-83.
10. Nagase H, Woessner JF Jr. Role of endogenous proteinases in the degradation of cartilage matrix. In: Woessner JF, Howell DS, editors. Joint cartilage degradation. New York: Marcel Dekker; 1993. p. 159-85.
11. Stricklin GP, Bauer EA, Jeffrey JJ, Eisen AZ. Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry 1977;16:1607-15.
12. Hasty KA, Jeffrey JJ, Hibbs MS, Welgus HG. The collagen substrate specificity of human neutrophil collagenase. J Biol Chem 1987;262:10048-52.
13. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
14. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase: inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 1995;270:5872-6.
15. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272: 2446-51.
16. Dodge GR, Pidoux I, Poole AR. The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study. Matrix 1991;11:330-8.
17. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96:2859-69.
18. Kozaci LD, Buttle DJ, Hollander AP. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum 1997;40:164-74.
19. Wolfe GC, MacNaul KL, Buechel FF, McDonnell J, Hoerrner LA, Lark MW, et al. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage: quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis. Arthritis Rheum 1993;36:1540-7.
20. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36:372-9.
21. Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993;36:181-9.
22. Tetlow LC, Woolley DE. Comparative immunolocalisation studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br J Rheumatol 1998;37:64-70.
23. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691-7.
24. Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Čeponis A, et al. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 1997;40:1391-9.
25. Westhoff CS, Freudiger D, Petrow P, Seyfert C, Zacher J, Kriegsmann J, et al. Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum 1999;42:1517-27.
26. Shingleton WD, Hodges DJ, Brick P, Cawston TE. Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol 1996;74: 759-75.
27. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
28. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-60.
29. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477:267-83.
30. Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF, et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 1998;41:1760-71.
31. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Differential effects of IL-1 and TNF alpha on the expression of stromelysin, collagenase and their natural inhibitor, TIMP, in rheumatoid human synovial fibroblasts. Matrix Suppl 1992;1: 198-9.
32. Cawston TE, Ellis AJ, Humm G, Lean E, Ward D, Curry V. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture. Biochem Biophys Res Commun 1995;215:377-85.
33. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ. Stromelysin is an activator of procollagenase: a study with natural and recombinant enzymes. Biochem J 1987;248:265-8.
34. Knäuper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A, et al. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 1993;295: 581-6.
35. Knäuper V, López-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-50.
36. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-5.
37. Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library: MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995;270:23013-20.
38. Matsumoto SI, Katoh M, Saito S, Watanabe T, Masuho Y. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Biochim Biophys Acta 1997;1354:159-70.
39. Pei D. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem 1999;274: 8925-32.
40. Velasco G, Cal S, Merlos-Suárez A, Ferrando AA, Alvarez S, Nakano A, et al. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res 2000;60:877-82.
41. Pei D, Weiss SJ. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995;375:244-7.
42. He C, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A 1989;86: 2632-6.
43. Eeckhout Y, Vacs G. Further studies on the activation of procollagenase, the latent precursor of hone collagenase: effects of lysomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 1977;166:21-31.
44. Werb Z, Mainardi CL, Vater CA, Harris ED Jr. Endogenous activation of latent collagenase by rheumatoid synovial cells: evidence for a role of plasminogen activator. N Engl J Med 1977;296:1017-23.
45. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997;72:1-22.
46. Treadwell BV, Pavia M, Towle CA, Cooley VJ, Mankin HJ. Cartilage synthesizes the serine protease inhibitor PAI-1: support for the involvement of serine proteases in cartilage remodeling. J Orthop Res 1991;9:309-16.
47. Bryson H. An investigation into the possible role(s) of the plasminogen activation system in cartilage proteoglycan breakdown [dissertation]. Sheffield (UK): University of Sheffield; 1998.
48. Kummer JA, Abbink JJ, de Boer J-P, Roem D, Nieuwenhuys EJ, Kamp AM, et al. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. Arthritis Rheum 1992;35:884-93.
49. Belcher C, Fawthrop F, Bunning R, Doherty M. Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Ann Rheum Dis 1996;55:230-6.
50. Martel-Pelletier J, Faure M-P, McCollum R, Mineau F, Cloutier J-M, Pelletier J-P. Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. J Rheumatol 1991;18:1863-71.
51. Campbell IK, Piccoli DS, Butler DM, Singleton DK, Hamilton JA. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator. Biochim Biophys Acta 1988;967:183-94.
52. Campbell IK, Last K, Novak U, Lund LR, Hamilton JA. Recombinant human interleukin-1 inhibits plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Biochem Biophys Res Commun 1991;174:251-7.
53. Hodges DJ, Reid DG, Rowan AD, Clark IM, Cawston TE. Preparation of recombinant tissue inhibitor of metalloproteinases-1 (TIMP-1) in high yield and identification of a hydrophobic surface feature. Eur J Biochem 1998;257:562-9.
54. Powers JC, Kam CM, Narasimhan L, Oleksyszyn J, Hernandez MA, Ueda T. Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design. J Cell Biochem 1989;39:33-46.
55. Bryson H, Bunning RA, Feltell R, Kam CM, Kerrigan J, Powers JC, et al. A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokines. Arch Biochem Biophys 1998;355: 15-25.
56. Bergmann I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Biochem 1963;35:1961-5.
57. Ellis AJ, Curry VA, Powell EK, Cawston TE. The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor. Biochem Biophys Res Commun 1994;201:94-101.
58. Cawston TE, Barrett AJ. A rapid and reproducible assay for collagenase using [14C] acetylated collagen. Anal Biochem 1979; 99:340-5.
59. Koshy PJT, Rowan AD, Life PF, Cawston TE. 96-well plate assays for measuring collagenase activity using (3)H-acetylated collagen. Anal Biochem 1999;275:202-7.
60. Sah RL, Chen AC, Grodzinsky AJ, Trippel SB. Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. Arch Biochem Biophys 1994;308:137-47.
61. Luyten FP, Hascall VC, Nissley SP, Morales TI, Reddi AH. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys 1988;267:416-25.
62. Tyler JA. Insulin-like growth factor 1 can decrease degradation and promote synthesis of protcoglycan in cartilage exposed to cytokines. Biochem J 1989;260:543-8.
63. Hascall VC, Handley CJ, McQuillan DJ, Hascall GK, Robinson HC, Lowther DA. The effect of serum on biosynthesis of proteoglycans by bovine articular cartilage in culture. Arch Biochem Biophys 1983;224:206-23.
64. Chin JR, Murphy G, Werb Z. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase: biosynthesis, isolation, characterization, and substrates. J Biol Chem 1985;260: 12367-76.
65. Nixon JS, Bottomley KM, Broadhurst MJ, Brown PA, Johnson WH, Lawton G, et al. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro. Int J Tissue React 1991;13:237-41.
66. Saito S, Katoh M, Masumoto M, Matsumoto S, Masuho Y. Collagen degradation induced by the combination of IL-1α, and plasminogen in rabbit articular cartilage explant culture. J Biochem (Tokyo) 1997;122:49-54.
67. Cawston TE, Billington C, Cleaver CS, Elliott SF, Hui W, Koshy PJ, et al. The regulation of MMPs and TIMPs in cartilage turnover. Ann N Y Acad Sci 1999;878:120-9.
68. Kam CM, Fujikawa K, Powers JC. Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: new anticoagulants. Biochemistry 1988;27:2547-57.
69. Collier S, Ghosh P. The role of plasminogen in interleukin-1 mediated cartilage degradation. J Rheumatol 1988;15:1129-37.
70. Gavrilovic J, Murphy G. The role of plasminogen in cell-mediated collagen degradation. Cell Biol Int Rep 1989;13:367-75.
71. Hashimoto K, Nagao Y, Kato K, Mori Y, Ito A. Human urinary trypsin inhibitor inhibits the activation of pro-matrix metalloproteinases and proteoglycans release in rabbit articular cartilage. Life Sci 1998;63:205-13.
72. 2-macroglobulin and TIMP. Inflamm Res 1996;45: 464-72.
73. Rao CN, Mohanam S, Puppala A, Rao JS. Regulation of proMMP-1 and proMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor. Biochem Biophys Res Commun 1999;255:94-8.
74. Van der Laan WH, Pap T, Ronday HK, Grimbergen JM, Huisman LGM, TeKoppele JM, et al. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor. Arthritis Rheum 2000;43: 1710-8.
75. 1-antitrypsin synthesis in human articular chondrocytes by interleukin-6-type cytokines: evidence for a local acute-phase response in the joint. Arthritis Rheum 1999;42:1936-45.
76. Hamilton JA, Leizer T, Piccoli DS, Royston KM, Butler DM, Croatto M. Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblasts. Biochem Biophys Res Commun 1991;180:652-9.
77. Benbow U, Schoenermark MP, Mitchell TI, Rutter JL, Shimokawa K, Nagase H, et al. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type 1 collagen. J Biol Chem 1999;274:25371-8.
78. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999;274:13066-76.
79. 342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. Arthritis Rheum 1999;42:2074-84.
80. Buttle DJ, Saklatvala J. Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation. Biochem J 1992;287:657-61.
81. Buttle DJ, Handley CJ, Ilic MZ, Saklatvala J, Murata M, Barrett AJ. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases: evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum 1993;36: 1709-17.
82. Imai K, Ohta S, Matsumoto T, Fujimoto N, Sato H, Seiki M, et al. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol 1997;151:245-56.
83. Cowell S, Knäuper V, Stewart ML, D'Ortho MP, Stanton H, Hembry RM, et al. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 1998;331:453-8.
84. Knäuper V, Will H, López-Otin C, Smith B, Atkinson SJ, Stanton H, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J Biol Chem 1996;271:17124-31.
85. Van der Zee E, Everts V, Beertsen W. Cytokine-induced endogenous procollagenase stored in the extracellular matrix of soft connective tissue results in a burst of collagen breakdown following its activation. J Periodontal Res 1996;31:483-8.
86. Birkedal-Hansen H, Lin HY, Birkedal-Hansen B, Windsor LJ, Pierson MC. Degradation of collagen fibrils by live cells: role of expression and activation of procollagenase. Matrix Suppl 1992;1: 368-74.